Leaflet SANDOSTATIN LAR 10mg powder and solvent for prolonged-release suspension for intramuscular injection
Indicated for: acromegaly; neuroendocrine tumors
Route of administration: intramuscular
Substance: octreotide (somatostatin analogue)
ATC: H01CB02 (Systemic hormonal preparations, excluding sex hormones and insulins | Hypothalamic hormones | Somatostatin and analogues)
Use during pregnancy only on medical advice.
Octreotide is a synthetic analog of somatostatin used for the treatment of acromegaly, neuroendocrine tumors, and other conditions associated with hormonal hypersecretion. It works by inhibiting the release of hormones such as growth hormone, insulin, and glucagon.
The medication is administered as subcutaneous or intramuscular injections, as directed by a doctor. The dosage and frequency of administration are adjusted based on the patient's response to treatment.
Patients should be monitored for potential side effects, such as nausea, diarrhea, or pain at the injection site. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, diarrhea, abdominal pain, and pain at the injection site. In rare cases, severe reactions such as hyperglycemia or cholelithiasis may occur. Patients should be informed of these risks before starting treatment.
General data about SANDOSTATIN LAR 10mg
- Substance: octreotide
- Date of latest medicines list: 01-01-2019
- Product code: W42954001
- Concentration: 10mg
- Pharmaceutical form: powder and solvent for prolonged-release suspension for intramuscular injection
- Quantity: 1
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for octreotide
- 0.1mg/ml
- 100mcg/ml
- 10mg
- 20mg
- 30mg
- 500mcg/ml
- 50mcg/ml